Here's what we'll cover
Here's what we'll cover
A K-Pop Star's Weight Loss Story Is Getting a Lot of Attention
Shindong, a member of the long-running South Korean group Super Junior, recently shared that he lost around 37 kg (roughly 82 pounds) in just five months while using Wegovy. He has since stopped the medication, and his story has sparked conversation across Asia and in weight loss communities worldwide.
His comments about having an "obesity gene" struck a chord. If you have ever felt like your body fights harder against you than it does for others, you know exactly what he is talking about.
This article is not about celebrity gossip. It is about what Shindong's experience actually tells us about semaglutide, what realistic expectations look like, and what you need to think about before starting or stopping a GLP-1 medication.
What Is Wegovy and How Does It Work?
Wegovy is a brand-name injectable medication containing semaglutide, the same active ingredient found in Ozempic. It is FDA-approved specifically for chronic weight management in adults with obesity or overweight plus at least one weight-related health condition.
Semaglutide works by mimicking a hormone called GLP-1 (glucagon-like peptide-1). This hormone is released naturally after eating, and it signals your brain to feel full, slows digestion, and reduces appetite. For many people, this means eating significantly less without constant willpower battles.
Wegovy is dosed at up to 2.4 mg once weekly, which is higher than the standard Ozempic dosing used for type 2 diabetes. That higher dose is part of why Wegovy tends to produce stronger weight loss outcomes in clinical trials.
Is Losing 37 kg in Five Months Realistic?
Shindong's result is striking, but it sits at the high end of what clinical data shows. In the STEP 1 trial, the landmark study of semaglutide for obesity, participants lost an average of about 14.9% of their body weight over 68 weeks. Some people lost significantly more.
A few factors could explain a result as large as 37 kg in five months:
Starting Weight Matters
People with higher starting body weights often see larger absolute weight losses (total pounds or kilograms), even if their percentage of body weight lost is similar to others.
Lifestyle Changes Amplify Results
Clinical trials show that semaglutide works best alongside reduced caloric intake and increased physical activity. If Shindong made significant dietary changes alongside the medication, that combination could produce dramatic results.
Individual Response Varies
Genetics, gut microbiome, baseline metabolism, and hormonal factors all influence how a person responds to semaglutide. Some people are strong responders. Others see more modest results, and that is not a reflection of effort.
The bottom line: 37 kg in five months is at the top of the range, not the guaranteed outcome. Setting realistic expectations with your provider before you start is one of the most important conversations you can have.
The "Obesity Gene" Comment: What Science Actually Says
Shindong's reference to an "obesity gene" is not just celebrity storytelling. The genetics of obesity are real and well-studied.
Variants in genes like FTO, MC4R, and POMC have been linked to increased appetite, lower satiety signaling, and a higher tendency to store fat. For people carrying these variants, hunger is not just psychological. It is biological.
Here is where GLP-1 medications become particularly relevant. Semaglutide works partly by amplifying satiety signals that these genetic variants can suppress. In other words, the medication is not just helping you eat less through willpower. It is working at a hormonal level to counteract some of what your genes are doing.
This is why many endocrinologists and obesity medicine specialists now describe obesity as a chronic condition requiring ongoing medical management, similar to how high blood pressure or high cholesterol is managed long-term. You would not stop blood pressure medication because your numbers improved. The same logic often applies here.
What Happens When You Stop Wegovy?
Shindong reportedly stopped taking Wegovy after his weight loss, and this is the part of the story that deserves the most attention for anyone considering a GLP-1 medication.
The STEP 4 trial specifically studied what happens after stopping semaglutide. Participants who discontinued the medication regained about two-thirds of the weight they had lost within one year. This is not a failure. It reflects what the research consistently shows: GLP-1 medications work while you take them.
Why Weight Returns
When you stop semaglutide, the appetite-suppressing hormone signals it was amplifying go away. Your body's hunger hormones often rebound, sometimes to levels higher than before treatment started. This is a documented biological response, not a lack of discipline.
This Does Not Mean You Should Never Stop
There are valid reasons to discontinue a GLP-1 medication: side effects, cost, personal choice, or reaching a point where lifestyle changes alone can maintain results. But it should be a planned, provider-guided decision, not an abrupt stop.
If you are considering stopping your GLP-1 medication, talk to your provider about a gradual tapering plan and strategies to maintain your results through diet and activity.
Comparing Wegovy to Other GLP-1 Options
Wegovy is not the only option for weight loss in the GLP-1 class. Mounjaro (tirzepatide) is another injectable medication that targets both GLP-1 and GIP receptors, and it has shown even larger average weight loss in trials.
Your best option depends on your health history, insurance coverage, and what your provider recommends. No single medication is right for everyone.
What Wegovy Costs and How to Make It More Affordable
One reason stories like Shindong's resonate beyond celebrity circles is that they make people curious about access. The reality is that Wegovy is expensive without insurance coverage.
Novo Nordisk, the maker of Wegovy, offers a savings program for eligible commercially insured patients. Telehealth platforms that specialize in GLP-1 prescribing often have lower overall costs than traditional clinics.
If cost is a barrier, checking the GLP-1 Coupons page can point you toward current savings options, and comparing Best Providers can help you find a prescriber who fits your budget.
Questions to Ask Your Doctor Before Starting Wegovy
Shindong's story may have you motivated to explore Wegovy for yourself. Before your appointment, having the right questions ready will help you get more out of the conversation.
- Am I a good candidate for Wegovy based on my BMI and health history?
- What weight loss timeline is realistic for someone with my starting weight?
- How do we handle side effects, especially nausea, in the early weeks?
- What is the plan if I want to stop the medication eventually?
- Are there genetic or metabolic factors in my case that might affect how I respond?
- Does my insurance cover Wegovy, and what savings programs apply to me?
A good provider will welcome these questions. If you do not yet have a GLP-1 prescriber, comparing Best Providers is a practical starting point.
No waiting list. No insurance needed.
Frequently Asked Questions
How much weight can you lose on Wegovy in 5 months?
Results vary widely by individual. In clinical trials, most people lose between 10% and 15% of their body weight over roughly 68 weeks. Dramatic losses like Shindong's 37 kg in five months are possible but fall at the high end of outcomes, typically seen in people with higher starting weights who also make significant dietary changes.
What happens if you stop taking Wegovy?
Most people regain a significant portion of the weight they lost, often two-thirds within a year, according to the STEP 4 clinical trial. This is a biological response to the removal of the medication's appetite-suppressing effects, not a personal failure. Stopping should ideally be discussed and planned with your provider.
Is semaglutide effective if you have a genetic tendency toward obesity?
Yes. Semaglutide works at a hormonal level to enhance satiety signals that genetic variants in genes like FTO or MC4R can suppress. Many people with a strong family history of obesity are good candidates for GLP-1 therapy precisely because their hunger is biologically driven.
What is the difference between Wegovy and Ozempic?
Both contain semaglutide, but Wegovy is FDA-approved specifically for weight management and is dosed at up to 2.4 mg weekly. Ozempic is FDA-approved for type 2 diabetes at lower doses and is sometimes prescribed off-label for weight loss. The higher dose in Wegovy typically produces stronger weight loss results.
How much does Wegovy cost per month without insurance?
Without insurance, brand-name Wegovy typically costs between $1,300 and $1,600 per month in the United States. Savings cards from the manufacturer can reduce this significantly for commercially insured patients. Compounded semaglutide from telehealth platforms may cost $200 to $500 monthly, though availability depends on FDA regulatory status.
How long do you have to stay on Wegovy?
Wegovy is currently approved as a long-term treatment for chronic weight management, meaning it is designed to be used ongoing rather than for a set short period. Your provider will help you decide how long to continue based on your results, health goals, and any side effects you experience.
What Shindong's Story Actually Means for You
Celebrity weight loss stories are useful when they spark real conversations, and not when they set unrealistic benchmarks. Shindong's experience with Wegovy illustrates several things that align closely with what clinical research shows.
GLP-1 medications can produce significant, life-changing weight loss. They work better alongside lifestyle changes. They address biological drivers of weight gain, including genetic ones. And stopping them without a plan often means regaining much of what was lost.
None of that is a reason to avoid these medications. It is a reason to go in with clear eyes and a solid plan.
This Is a Chronic Condition, Not a Quick Fix
Obesity medicine specialists increasingly describe excess weight as a chronic condition, similar to diabetes or hypertension. That framing matters because it shifts the goal from "lose weight and stop treatment" to "find a sustainable approach that works long-term for your body."
For some people, that means staying on a GLP-1 medication indefinitely. For others, it means using it as a tool to reach a healthier weight while building habits that make long-term maintenance more achievable. There is no single right answer, but your provider should help you figure out which approach fits your situation.
Your Next Step
If you are curious about whether Wegovy or another GLP-1 option is right for you, start by checking eligibility with a qualified provider. Costs, coverage, and access vary significantly depending on where you live and which platform you use.
You can compare Best Providers to find a GLP-1 prescriber that fits your needs and budget, browse GLP-1 Coupons for current savings on Wegovy and other medications, or explore side-by-side comparisons of Wegovy, Ozempic, and Mounjaro to understand your options.
Whatever you decide, make the decision with your doctor and with accurate information. Not based on what worked for a celebrity, but on what the evidence says about your specific biology and goals.